Elisabeth Botelho-Nevers, MD, PHD

Service d’infectiologie, CIC1408, Inserm, CHU de Saint-Etienne, 42055 Saint-Etienne, France; F-CRIN, I REIVAC/COVIREIVAC, France, France

Disclosure(s): Janssen: Board Member; Pfizer: Board Member; Sanofi Pasteur: Board Member

Poster(s):

• 1954 - Immunogenicity against SARS CoV-2 ancestral strain and variants of two new COVID-19 recombinant adjuvanted vaccines compared to BNT162b2 as a third dose following two doses of BNT162b2: a single-blinded multicenter randomized controlled trial
  Saturday, October 22, 2022

  12:15 PM – 1:30 PM US ET